Insider · CIK 0002022303
Dallan Murray
Files at SRPT (Sarepta Therapeutics, Inc.). First filing May 6, 2024, latest May 6, 2024.
In brief
Dallan Murray files SEC Form 4 as officer at SRPT (Sarepta Therapeutics, Inc.). Since May 6, 2024, Dallan Murray has reported 0 open-market buys worth $0 and 1 open-market sell worth $509k, the latest filed on May 6, 2024.
A track record needs three past buys with six months of prices behind them; Dallan Murray has 0, so none is measured yet.
The newest scored trade: sold $509k of SRPT on May 2, 2024, filed May 6, 2024, scored 18 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SRPT: Sarepta Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 18Weak | Sarepta Therapeutics, Inc. | $509k 3,635 shares | -17% | +94% from low-17% from high |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 21, 2024 | SRPT Sarepta Therapeutics, Inc. | MOption exercise Common Stock | +6,250 | - | - | 24,375 | Jun 25, 2024 |
| Jun 24, 2024 | SRPT Sarepta Therapeutics, Inc. | FTax withholding Common Stock | -2,352 | $164.64 | $387k | 22,023 | Jun 25, 2024 |
| Jun 21, 2024 | SRPT Sarepta Therapeutics, Inc. | AGrant or award Performance Stock Unitsderivative | +5,500 | $0.00 | $0 | 5,500 | Jun 25, 2024 |
| Jun 21, 2024 | SRPT Sarepta Therapeutics, Inc. | AGrant or award Performance Stock Unitsderivative | +6,250 | $0.00 | $0 | 6,250 | Jun 25, 2024 |
| Jun 21, 2024 | SRPT Sarepta Therapeutics, Inc. | MOption exercise Performance Stock Unitsderivative | -6,250 | $0.00 | $0 | 0 | Jun 25, 2024 |
| May 2, 2024 | SRPT Sarepta Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,635 | $140.00 | $509k | 18,125 | May 6, 2024 |
Questions about Dallan Murray
Answered from the filings on this page, as of the latest one.
Is Dallan Murray buying or selling?
Not in the last 12 months. Dallan Murray's latest open-market trade on SEC Form 4 was sold $509k of SRPT on May 2, 2024.
How did Dallan Murray's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dallan Murray has 0.
Where does Dallan Murray file Form 4?
Dallan Murray has filed Form 4 at SRPT (Sarepta Therapeutics, Inc.) as Chief Customer Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.